Earth Science Tech Inc
Earth Science Tech, Inc., together with its subsidies, focuses on health and wellness industry. It engages in compounding pharmaceuticals, telemedicine, and real estate development activities. The company also operates Peaks, a telemedicine referral platform focused on health and wellness for men and women; and pharmacies under the RxCompound and Mister Meds name. In addition, it is involved in t… Read more
Earth Science Tech Inc - Asset Resilience Ratio
Earth Science Tech Inc (ETST) has an Asset Resilience Ratio of 13.92% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2025)
This chart shows how Earth Science Tech Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Earth Science Tech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.13 Million | 13.92% |
| Total Liquid Assets | $1.13 Million | 13.92% |
Asset Resilience Insights
- Moderate Liquidity: Earth Science Tech Inc has 13.92% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Earth Science Tech Inc Industry Peers by Asset Resilience Ratio
Compare Earth Science Tech Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Earth Science Tech Inc (2024–2025)
The table below shows the annual Asset Resilience Ratio data for Earth Science Tech Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 9.13% | $645.44K | $7.07 Million | +8.89pp |
| 2024-03-31 | 0.24% | $9.35K | $3.88 Million | -- |